Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Financial Statements
- Click here to download Becton Dickinson & Co.'s Income Statement
- Click here to download Becton Dickinson & Co.'s Balance Sheet
- Click here to download Becton Dickinson & Co.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Thomas Polen
Key Statistics
- Stock Price: $247.45
- Dividend Yield: 1.5%
- Market Capitalization: $71,488,799,900
- Shares Outstanding: 288,902,000
- Number of Employees: 77,000
- Trailing 12-Month EPS: $4.2
- Trailing 12-Month DPS: $3.7
- Payout Ratio: 88.1%
Important Dates
- Next Earnings Date: 2024-05-02
- Next Ex-Dividend Date: 2024-03-07
Price Trends
- Current Stock Price: $247.45
- 52-week high: $284.02
- 52-week low: $228
- 200-day moving average: $243.51
- 50-day moving average: $239.56
Performance
- 1-Month Price Return: 3.9%
- 3-Month Price Return: 1.9%
- 6-Month Price Return: -3.5%
- 1-Year Price Return: 2.5%
- 2-Year Price Return: -3.1%
- 5-Year Price Return: 8.8%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast